Valuation: Advanced Medical Solutions Group plc

Capitalization 460M 616M 531M 486M 847M 59.61B 869M 5.8B 2.26B 28.06B 2.31B 2.26B 97.99B P/E ratio 2025
48.2x
P/E ratio 2026 * 31x
Enterprise value 513M 687M 592M 543M 945M 66.48B 969M 6.47B 2.52B 31.3B 2.58B 2.52B 109B EV / Sales 2025
2.27x
EV / Sales 2026 * 2.04x
Free-Float
95.21%
Yield 2025
1.31%
Yield 2026 * 1.5%
1 day-1.76%
1 week-15.73%
Current month-13.99%
1 month-21.13%
3 months-1.65%
6 months+0.72%
Current year-4.13%
1 week 187
Extreme 187
256.5
1 month 187
Extreme 187
266.35
Current year 187
Extreme 187
272
1 year 187
Extreme 187
272
3 years 165.6
Extreme 165.6
275.83
5 years 165.6
Extreme 165.6
347
10 years 165.6
Extreme 165.6
374
Manager TitleAgeSince
Chief Executive Officer - 28/02/2026
Chief Executive Officer 59 31/12/2010
Director of Finance/CFO 54 31/12/2018
Director TitleAgeSince
Director/Board Member 59 31/12/2010
Director/Board Member 54 31/12/2018
Chairman 68 30/03/2025
Change 5d. change 1-year change 3-years change Capi.($)
-1.88%-15.73%+6.31%-12.92% 616M
-0.14%+0.70%-38.08%-55.58% 14.13B
-1.70%-7.01%+120.17%+108.60% 4.8B
+1.04%+3.28%+369.94%+176.70% 3.67B
-0.63%-5.24%-40.53%-29.86% 2.58B
0.00%-2.82%-41.62%-71.67% 1.98B
0.00%-3.57%-2.41%-33.61% 1.63B
+0.78%-3.73%-34.18%-49.41% 1.1B
+1.10%+1.10%+28.67%+53.33% 1.05B
+0.18%-7.56%+29.16%-0.88% 1.02B
Average -0.08%-3.75%+39.74%+8.47% 3.26B
Weighted average by Cap. -0.19%-1.38%+37.83%+3.19%

Financials

2025 2026 *
Net sales 229M 306M 264M 242M 422M 29.65B 432M 2.88B 1.12B 13.96B 1.15B 1.12B 48.74B 246M 330M 284M 260M 454M 31.91B 465M 3.1B 1.21B 15.02B 1.24B 1.21B 52.46B
Net income 12.06M 16.15M 13.93M 12.76M 22.23M 1.56B 22.79M 152M 59.22M 736M 60.61M 59.32M 2.57B 14.35M 19.22M 16.58M 15.19M 26.45M 1.86B 27.12M 181M 70.48M 876M 72.13M 70.59M 3.06B
Net Debt 52.99M 70.98M 61.22M 56.08M 97.69M 6.87B 100M 668M 260M 3.23B 266M 261M 11.3B 42.14M 56.44M 48.68M 44.59M 77.68M 5.46B 79.63M 531M 207M 2.57B 212M 207M 8.98B
Logo Advanced Medical Solutions Group plc
Advanced Medical Solutions Group plc is an independent developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. Its surgical products, including tissue adhesives, suture, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, Peters Surgical, Ifabond, Vitalitec and Seal-G. It also supplies wound care dressings, such as silver alginates, alginates and foams through its ActivHeal brand, and under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit comprises a multi-product portfolio of advanced woundcare dressings and a portfolio of specialist medical bulk materials and multi-layer woundcare and bio-diagnostics products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel.
Employees
1,500
Date Price Change Volume
20/05/26 209.00 p -1.65% 187,202
19/05/26 212.50 p +5.46% 11,159,320
18/05/26 201.50 p -18.42% 14,060,000
15/05/26 247.00 p -3.52% 781,188
14/05/26 256.00 p +3.23% 1,924,339
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.125GBP
Average target price
2.779GBP
Spread / Average Target
+30.76%

Quarterly revenue - Rate of surprise